May 02 (Reuters) - Alnylam Pharmaceuticals Q1 basic EPS USD -0.52. * Q1 operating income USD -43.435 million * Q1 adjusted net income USD -20.666 million vs. IBES estimate USD -143.2 million * Q1 net income USD -65.935 million
May 02 (Reuters) - Alnylam Pharmaceuticals Q1 basic EPS USD -0.52. * Q1 operating income USD -43.435 million * Q1 adjusted net income USD -20.666 million vs. IBES estimate USD -143.2 million * Q1 net income USD -65.935 million
Comments